Diseases, Conditions, Syndromes

Researchers move closer to new vaccine for killer TB

Scientists said Tuesday they are closing in on a new game-changing vaccine for tuberculosis, the world's deadliest infectious disease that claimed some 1.5 million lives last year.

Diseases, Conditions, Syndromes

Candidate tuberculosis vaccine in phase II/III trial

Tuberculosis remains the most deadly infectious diseases in the world. In particular, the growing number of multiresistant microbes is a cause of great concern to doctors and healthcare policymakers. At least a dozen candidate ...

Diseases, Conditions, Syndromes

Regional cooperation to combat tuberculosis

Tuberculosis can be cured and could be eradicated. For this to happen, however, patients have to receive the right treatment. Researchers at the Makerere University and the University of Zurich were able to demonstrate that ...

Diseases, Conditions, Syndromes

A genetic variation may increase tuberculosis susceptibility

Researchers have shown that a single nucleotide change in a gene that affects production of hepcidin—a peptide involved in inflammation, immunity, and control of iron levels—is associated with greater susceptibility to ...

Diseases, Conditions, Syndromes

New trials offer hope for TB treatment

Researchers at the University of St Andrews are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.

Diseases, Conditions, Syndromes

Possible breakthrough in tuberculosis research on the horizon

"New weapon in fight against the deadliest disease! Medicine can be used to treat existing illness and prevent reoccurrence." These headlines were published 125 years ago and shook up not only the world of science and medicine, ...

page 1 from 4